To what extent the difference in serum osteoprotegerin levels in PCOS may influence or correlate with BMD remains to be determined in future studies, particularly given that higher circulating osteoprotegerin levels are often found in patients with osteoporosis (103). This evidence concerns the gene TNFRSF11B and polycystic ovary syndrome.